Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis

INTRODUCTION: Novel oral anticoagulants (NOACs) have been approved for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). A large number of patients are on NOACs when they present for AF ablation. We intended to evaluate the safety and efficacy of NO...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallakati, Ajay, Sharma, Abhishek, Madmani, Mohammed, Reddy, Madhu, Kanmanthareddy, Arun, Gunda, Sampath, Lakkireddy, Dhanunjaya, Lewis, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906088/
https://www.ncbi.nlm.nih.gov/pubmed/27105998
http://dx.doi.org/10.1007/s40119-016-0061-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906088/
https://www.ncbi.nlm.nih.gov/pubmed/27105998
http://dx.doi.org/10.1007/s40119-016-0061-7

Ejemplares similares